Evidence map›Paper›PMID 30887486›Full record

ArticleSeminars in thrombosis and hemostasis2019

Comprehensive Coagulation Profiling at the Point-of-Care Using a Novel Laser-Based Approach.

Seemantini K Nadkarni

Abstract read
In one paragraph

Article in Seminars in thrombosis and hemostasis, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Seemantini K NadkarniWellman Center for Photomedicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.

Funding

Integrated Coagulation Sensing to Predict Hemorrhage and Guide TransfusionsR01HL142272 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI Christoph Gunther Stanislaw Nabzdyk, Seemantini K Nadkarni · 2018 to 2026
$4.6M
Blood Coagulation Monitoring at the Point of CareR01HL119867 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI NADKARNI, SEEMANTINI K · 2014 to 2018
$2.2M
An Optical Sensor for Anticoagulation Self-TestingR21EB023012 · NIBIB · MASSACHUSETTS GENERAL HOSPITAL · PI NADKARNI, SEEMANTINI K · 2017 to 2018
$423k
NHLBI NIH HHS R01 HL119867NHLBI NIH HHS R01 HL142272NIBIB NIH HHS R21 EB023012
6 · The paper itself

Abstract

Delays in identifying internal bleeding are life-threatening, thus underscoring the need for rapid and comprehensive coagulation profiling at the bedside. The authors review a novel optical coagulation profiler that measures several coagulation metrics including prothrombin time, activated clotting time, clot polymerization rate (α-angle), clot stiffness (maximum amplitude), fibrinolysis (LY), and platelet function, using a single multifunctional instrument. The optical profiler is based on the principles of Laser Speckle Rheology that quantifies tissue viscoelasticity from light scattering patterns called laser speckle. To operate the optical profiler, whole blood (40 μL) is loaded into a disposable cartridge, laser speckle patterns are recorded via a camera, and the viscoelasticity of clotting blood is estimated from speckle intensity fluctuations. By monitoring alterations in viscoelastic moduli over time during clot initiation, thrombin generation, fibrin crosslinking, clot stabilization, and LY, global coagulation parameters are obtained within 10 minutes using a drop of whole blood. Clinical testing in over 500 patients to date has confirmed the accuracy of the optical profiler for comprehensively assessing coagulation status against conventional coagulation tests and thromboelastography. Recent studies have further demonstrated the capability to quantify platelet aggregation induced by adenosine diphosphate in a drop of platelet-rich-plasma in the absence of applied shear stress. Together, these studies demonstrate that global coagulation profiling in addition to platelet function may be accomplished using a single multifunctional device. Thus, by enabling rapid and comprehensive coagulation and platelet function profiling at the bedside, the optical profiler will likely advance the capability to identify and manage patients with an elevated risk for hemorrhage.

Indexed as

HumansLaser TherapyPoint-of-Care Systems

Identifiers

PMID30887486
PMCPMC7350951

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.